Hovione brings a new capsule filling unit into operation

| By | API, Drug Manufacturing, Technological Equipment

Hovione, a Portuguese pharmaceutical company, announced that a new MG2 Tekna Precision Capsule filling unit is now online in its facilities. This investment reinforces Hovione’s Services portfolio in inhalation product development capabilities, which include proprietary particle engineering technologies as well as formulation and capsule filling capacity to support from development to commercial scale projects.

Hovione’s new MG2 Tekna Precision Capsule filling unit complements our offering in encapsulation for inhalation products and has capacity for up to 110 000 capsules per hour.  In parallel Hovione has installed capacity in particle engineering suitable for inhalation, namely a multiple scale Spray Drying units for highly potent compounds, as well as a new wet polishing suite, and strengthened its analytical characterization toolbox.

From formulation composition, optimization and precision capsule filling with 100% fill weight check, to analytical characterization and scale-up to a commercial scale, Hovione can take product from the early proof of concept stages up to a fully developed and scaled process.

“We are excited to announce this new integrated offering, all at the same site where our scientists work together in the interface between particle engineering and final drug product for the benefit of an optimal product performance. This will allow us to support our customer’s inhalation projects at all scales and contribute to accelerate drug development and manufacturing timelines,” said Filipe Gaspar, Vice President R&D.

As a contract development and manufacturing organization (CDMO) with 58 years of experience, Hovione develops and manufactures active pharmaceutical ingredients (API) and offers contract manufacturing services that include development and manufacture of drug substance. Company has four FDA inspected sites in the USA, China, Ireland, and Portugal, and development laboratories in Lisbon and New Jersey.

SOURCE: hovione
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.